Actavis Completes Forest Laboratories Acquisition LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Product Prescribing

Allergan Product Prescribing and Labeling Information

Product name Patient Information
ACULAR® (ketorolac tromethamine ophthalmic solution) 0.5% PDF
ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4% PDF
ACUVAIL® (ketorolac tromethamine ophthalmic solution) 0.45% PDF
ACZONE® (dapsone) Gel 5% PDF
ALOCRIL® (nedocromil sodium ophthalmic solution) 2% PDF
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% PDF
AVAGE® (tazarotene) Cream 0.1% PDF
AZELEX® (azelaic acid cream) 20% PDF
BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5% PDF
BLEPH®-10 (sulfacetamide sodium ophthalmic solution, USP) 10% PDF
BLEPHAMIDE® (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% PDF
BLEPHAMIDE® (sulfacetamide sodium − prednisolone acetate ophthalmic suspension, USP) 10%/0.2% PDF
BOTOX® (onabotulinumtoxinA) PDF
BOTOX® Cosmetic (onabotulinumtoxinA) PDF
BOTOX® (onabotulinumtoxinA) Injection Needle PDF
COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% PDF
ELESTAT® (epinastine HCl ophthalmic solution) 0.05% PDF
FLUOROPLEX® (fluorouracil) 1% Topical Cream PDF
FML® (fluorometholone ophthalmic ointment) 0.1% PDF
FML® (fluorometholone ophthalmic suspension, USP) 0.1% PDF
FML FORTE® (fluorometholone ophthalmic suspension) 0.25% PDF
JUVÉDERM® Ultra PDF
JUVÉDERM® Ultra Plus PDF
JUVÉDERM® Ultra XC PDF
JUVÉDERM® Ultra Plus XC PDF
JUVÉDERM VOLUMA® XC PDF
LASTACAFT® (alcaftadine ophthalmic solution) 0.25% PDF
LATISSE® (bimatoprost ophthalmic solution) 0.03% PDF
LUMIGAN® 0.01% (bimatoprost ophthalmic solution) PDF
OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% PDF
OCUFLOX® (ofloxacin ophthalmic solution) 0.3% PDF
OZURDEX® (dexamethasone intravitreal implant) 0.7 mg PDF
POLYTRIM® (polymyxin B sulfate and trimethoprim ophthalmic solution, USP) PDF
PRED FORTE® (prednisolone acetate ophthalmic suspension, USP) 1% PDF
PRED MILD® (prednisolone acetate ophthalmic suspension, USP) 0.12% PDF
PRED-G® (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% PDF
PRED-G® (gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3%/1% PDF
PREVAGE® MD PDF
REFRESH CONTACTS® Contact Lens Comfort Drops PDF
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% PDF
SANCTURA® (trospium chloride) PDF
SANCTURA XR® (trospium chloride extended release capsules) PDF
TAZORAC® (tazarotene) Cream 0.05% and 0.1% PDF
TAZORAC® (tazarotene) Gel 0.05% and 0.1% PDF
VANIQA® (eflornithine hydrochloride) Cream, 13.9% PDF
ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% PDF
U.S. Products
Find the current product labeling information for other company products in our Product Database.
Labeling and Safety Information
Allergan Natrelle® Collection and Breast Aesthetics Product Labeling and Safety Information